Author information from the last article
Articles by Ole-Bjørn Tysnes
Treatment of motor symptoms in Parkinson's disease
- Espen Dietrichs,
- Guido Alves,
- Espen Benjaminsen,
- Krisztina Kunszt Johansen,
- Ole-Bjørn Tysnes
05.05.2023:
In recent years, the development of new therapies and improvements in our understanding of older therapies have led to changes in the management of Parkinson's disease. However, current Norwegian and international therapy recommendations present a range of different options as being equally viable...
Ventilation of patients with amyotrophic lateral sclerosis
- Ole-Bjørn Tysnes,
- Trygve Holmøy,
- Solfrid Indrekvam,
- Ove Fondenæs
14.05.2021:
Just under 10 % of patients with amyotrophic lateral sclerosis receive life-prolonging ventilation via a tracheostomy. There is no international consensus on the planning of life-prolonging invasive ventilation for patients with this disease. The annual incidence rate of amyotrophic lateral...
Use of advanced therapies for Parkinson’s disease in Norway
- Beriwan Ezat,
- Lasse Pihlstrøm,
- Jan Aasly,
- Ole-Bjørn Tysnes,
- Arild Egge,
- Espen Dietrichs
02.05.2017:
Parkinson’s disease is a chronic progressive neurodegenerative disorder characterised by motor impairments in the form of tremor, rigidity and akinesia/bradykinesia (1, 2). The incidence of Parkinson’s disease in Norway is 12.6 per 100 000 inhabitants per year, similar to that reported in other...
Investigation of suspected chronic fatigue syndrome/myalgic encephalopathy
- Jone Furlund Owe,
- Halvor Næss,
- Ivar Otto Gjerde,
- Jørn Eilert Bødtker,
- Ole-Bjørn Tysnes
09.02.2016:
The reported prevalence of CFS/ME is 0.2 – 3 % (7) – (9). In the period from 2008 – 12, 5 809 persons in Norway received the ICD-10 diagnosis G93.3 (10). This figure will include patients with CFS/ME, but it is not known whether all these fulfil the established criteria for this condition. The...